Skip to main content
. 2004 Dec;48(12):4528–4531. doi: 10.1128/AAC.48.12.4528-4531.2004

TABLE 1.

MICs of β-lactams for E. aerogenes LOR and CF23.04 isolates and for recombinant E. coli DH10B(pBK-TEM-121), DH10B(pBK-TEM-24), and DH10B

β-Lactama MIC (μg/ml) for the following isolateb:
E. aerogenes LOR E. coli DH10B(pBK-TEM-121) E. aerogenes CF24.03 E. coli DH10B(pBK-TEM-24) E. coli DH10B
Amoxicillin >512 >512 >512 >512 2
Amoxicillin-CLA 16 32 512 4 2
Ticarcillin >512 >512 >512 512 1
Ticarcillin-CLA 128 256 128 32 1
Piperacillin 32 64 128 128 1
Piperacillin-TZB 4 8 16 8 1
Cephalothin 8 16 >512 >512 4
Cefoxitin 4 2 128 2 2
Cefuroxime 8 8 >512 256 0.5
Ceftriaxone <0.06 <0.06 32 8 <0.06
Cefotaxime <0.06 <0.06 32 8 <0.06
Ceftazidime 128 256 512 256 <0.06
Aztreonam 8 16 512 256 0.06
Cefepime 2 4 4 4 0.06
Cefpirome 2 4 4 4 0.06
Imipenem 0.06 0.06 0.06 0.06 0.06
a

CLA, clavulanic acid at 2 μg/ml; TZB, tazobactam at 4 μg/ml.

b

E. aerogenes isolate LOR produced β-lactamase TEM-121, whereas E. aerogenes CF24.03 produced TEM-24 and AmpC-type β-lactamases. Recombinant E. coli DH10B(pBK-TEM-121) and E. coli DH10B(pBK-TEM-24) produced β-lactamases TEM-121 and TEM-24, respectively.